Stockscreener 앱 받기
1.38
12.66%
-0.20
시간 외 거래:
1.40
0.02
+1.45%
Celularity Inc 주식(CELU)의 최신 뉴스
CELU stock touches 52-week low at $1.55 amid market fluctuations - Investing.com India
CELU stock touches 52-week low at $1.55 amid market fluctuations By Investing.com - Investing.com South Africa
Celularity reports over $24 million in biomaterial revenue By Investing.com - Investing.com Australia
Celularity Inc. Announces Anticipated Revenues for Second and Third Quarters - Defense World
Celularity reports over $24 million in biomaterial revenue - Investing.com India
Celularity Receives Nasdaq Delisting Notice Over Filing Delay - Marketscreener.com
Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel - The Manila Times
Celularity reports progress on Nasdaq compliance and product sales - Investing.com
Celularity reports progress on Nasdaq compliance and product sales By Investing.com - Investing.com Australia
Celularity Provides Corporate Update - citybiz
CELUWCelularity Inc. Warrant Latest Stock News & Market Updates - StockTitan
Celularity faces Nasdaq delisting over reporting delays - Investing.com
Celularity faces Nasdaq delisting over reporting delays By Investing.com - Investing.com UK
Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal - ForexTV.com
Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc. - The Manila Times
Celularity expands biomaterials range with Rebound acquisition - Investing.com India
Celularity Inc SEC 10-Q Report - TradingView
Celularity (NASDAQ:CELU) Stock Price Down 8.8%Should You Sell? - MarketBeat
Amniotic Membrane Market to Grow by USD 2.7 Billion (2024-2028) with AI Impact Boosting Trends in Ophthalmic Surgery UseTechnavio Report - The Malaysian Reserve
BTIG maintains Buy rating on Cullinan Oncology stock - Investing.com
Cullinan Oncology maintains Buy rating from H.C. Wainwright with steady price target - Investing.com India
Trend Tracker for (CLS) - Stock Traders Daily
Cullinan Therapeutics (NASDAQ:CGEM) Earns Outperform Rating from Wedbush - MarketBeat
Caesars Entertainment Inc (CZR) stock: A year of ups and downs - US Post News
In the Green: Cerus Corp. (CERS) Closes at 1.97, Up/Down -4.37 from Previous Day - The Dwinnex
Creo Medical to get £25m boost from majority sale of its European business - Business Live
Medical device company to sell stake of subsidiary to Chinese manufacturerequity value of €72m - Insider Media
Objective long/short (CGEM) Report - Stock Traders Daily
CRL Stock to Gain From Strategic Neuroscience Partnership With CEBINA - Yahoo Finance
Cullinan Therapeutics Inc (CGEM)’s stock price in review: A technical analysis - US Post News
(CELC) Technical Pivots with Risk Controls - Stock Traders Daily
Creo Medical Partners with Micro-Tech for Strategic Growth - TipRanks
E Fund Management Co. Ltd. Purchases New Shares in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) - MarketBeat
State of New Jersey Common Pension Fund D Has $3.31 Million Stock Holdings in Caesars Entertainment, Inc. (NASDAQ:CZR) - Defense World
Cellectis (NASDAQ:CLLS) Coverage Initiated at StockNews.com - MarketBeat
Cullinan Therapeutics commences Phase 1 trial for lupus treatment By Investing.com - Investing.com Canada
Celcuity Inc. (NASDAQ:CELC) Short Interest Update - MarketBeat
Capricor shares gain as Oppenheimer raises price target to $15 - Investing.com
Cullinan Therapeutics (NASDAQ:CGEM) Shares Up 5.5% - MarketBeat
Certara (NASDAQ:CERT) Shares Up 5% - MarketBeat
How Is The Market Feeling About Celestica? - Benzinga
Should You Increase Your Holdings in Certara (CERT)? - Insider Monkey
Centerra Gold shares target raised on molybdenum unit outlook - Investing.com India
Views of Wall Street’s Leading Experts on Centerra Gold Inc. - SETE News
Centuri Holdings, Inc. (NYSE:CTRI) Short Interest Update - Defense World
Caesars Entertainment Inc’s latest rating changes from various analysts - Knox Daily
Celadon Pharmaceuticals Expands Share Capital - TipRanks
Certara (NASDAQ:CERT) Sees Strong Trading Volume - MarketBeat
Is Caesars Entertainment, Inc. (NASDAQ:CZR) the Best Las Vegas Stock To Buy Now? - Yahoo Finance
Analyzing Ratios: Cullinan Therapeutics Inc (CGEM)’s Financial Story Unveiled - The Dwinnex
Cullinan Oncology's stock gets buy rating after trial data - Investing.com
Does Cerus Corp. (CERS) offer a good opportunity for investors? - SETE News
Perhaps timely catching Cullinan Therapeutics Inc (CGEM) would be a good idea - SETE News
Cullinan Therapeutics Announces Submission of - GlobeNewswire
Oppenheimer & Co. Inc. Boosts Stock Position in Cintas Co. (NASDAQ:CTAS) - Defense World
Daiwa Securities Group Inc. Grows Position in Caesars Entertainment, Inc. (NASDAQ:CZR) - Defense World
Choreo LLC Purchases 6,289 Shares of Caesars Entertainment, Inc. (NASDAQ:CZR) - Defense World
Jupiter Asset Management Ltd. Acquires Shares of 977 Cencora, Inc. (NYSE:COR) - Defense World
Celanese Co. (NYSE:CE) Shares Acquired by Daiwa Securities Group Inc. - Defense World
Caesars Entertainment, Inc. (NASDAQ:CZR) Shares Bought by Royal London Asset Management Ltd. - Defense World
Celestica Inc. (CLS): Among the Worst Performing AI Stocks of Previous Week - Insider Monkey
1.11%
0.26%
자본화:
|
볼륨(24시간):